Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by Cavailles
Group name EquipeVC
Item Type Journal Article
Title Transcriptional repression of estrogen receptor alpha signaling by SENP2 in breast cancer cells
Creator Nait Achour et al.
Author T. Nait Achour
Author S. Sentis
Author C. Teyssier
Author A. Philippat
Author A. Lucas
Author L. Corbo
Author V. Cavailles
Author S. Jalaguier
Abstract Estrogen receptors (ERs) are ligand-activated transcription factors involved in many physiological and pathological processes, including breast cancer. Their activity is fine-tuned by posttranslational modifications, notably sumoylation. In the present study, we investigated the role of the small ubiquitin-related modifier (SUMO) protease, SUMO1/sentrin/suppressor of Mif 2-specific peptidase 2 (SENP2), in the regulation of ERalpha activity. We first found SENP2 to significantly repress estradiol-induced transcriptional activity in breast cancer cells (MCF7 and T47D). This effect was observed with a reporter plasmid and on endogenous genes such as TFF1 and CTSD, which were shown to recruit SENP2 in chromatin immunoprecipitation experiments. Using glutathione S-transferase pull-down, coimmunoprecipitation and proximity ligation assays, SENP2 was found to interact with ERalpha and this interaction to be mediated by the amino-terminal region of the protease and the hinge region of the receptor. Interestingly, we demonstrated that ERalpha repression by SENP2 is independent of its SUMO protease activity and requires a transcriptional repressive domain located in the amino-terminal end of the protease. Using small interfering RNA assays, we evidenced that this domain recruits the histone deacetylase 3 (HDAC3), to be fully active. Furthermore, using both overexpression and knockdown strategies, we showed that SENP2 robustly represses estrogen-dependent and independent proliferation of MCF7 cells. We provided evidence that this effect requires both the proteolytic and transcriptional activities of SENP2. Altogether, our study unravels a new property for a SUMO protease and identifies SENP2 as a classical transcription coregulator.
Publication Mol Endocrinol
Volume 28
Pages 183-96
Date Feb 2014
Journal Abbr Molecular endocrinology
DOI 10.1210/me.2013-1376
ISSN 1944-9917 (Electronic) 0888-8809 (Linking)
Tags *Gene Expression Regulation, Neoplastic, *Gene Silencing, Breast Neoplasms, Cell Proliferation, Cysteine Endopeptidases/*physiology, Estradiol/physiology, Estrogen Receptor alpha/*physiology, Female, Histone Deacetylases/metabolism, Humans, MCF-7 Cells, original, own, Promoter Regions, Genetic, Protein Binding, Protein Structure, Tertiary, Transcription, Genetic
Date Added 2018/11/14 - 12:10:52
Date Modified 2019/05/17 - 11:58:28
Notes and Attachments (Note)
(Note)
24422630 (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés